The ASX 200 closed lower on Thursday, shedding 0.52 of a per cent and setting a new 50-day low.
It's been a sea of red - materials and healthcare managed to stay afloat, but every other sector finished in the red.
Green
Anteris Technologies had a stellar day after reporting a pivotal quarter and advancing the PARADIGM trial for its DurAVR heart valve. Approvals in the US and Europe now allow patient recruitment to begin, and Denmark has already treated the first participants.
Core Lithium also shot up after announcing a revised reopening plan for its Finniss Project amidst higher lithium prices, boosting investor confidence.
Red
Webjet Group was down on its trading update - which revealed a drop in first-half revenue and earnings, despite confidence in its long-term strategy.
Xero was hit hard, despite reporting strong half-year results, with revenue and EBITDA both up over 20%.
#ASX200 #MarketUpdate #Investing #CoreLithium #AnterisTechnologies #Webjet #Xero #LithiumStocks #BiotechStocks